Shares of Oncimmune Holdings plc (LON:ONC – Get Free Report) fell 2.5% during trading on Thursday . The company traded as low as GBX 8 ($0.10) and last traded at GBX 9.95 ($0.12). 378,794 shares were traded during mid-day trading, an increase of 34% from the average session volume of 281,822 shares. The stock had previously closed at GBX 10.20 ($0.13).
Oncimmune Trading Up 4.9 %
The company has a debt-to-equity ratio of 806.85, a current ratio of 1.13 and a quick ratio of 0.63. The company has a market cap of £7.19 million, a PE ratio of -323.40 and a beta of 1.19. The firm’s 50 day moving average is GBX 13.59 and its 200 day moving average is GBX 14.82.
About Oncimmune
Oncimmune Holdings plc, an immunodiagnostics company, develops solutions for immuno-oncology, autoimmune disease and infectious diseases in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, an immunodiagnostic blood test for detecting and identifying lung cancer; ImmunoINSIGHTS that enables life science organizations to optimize drug development and delivery; SeroTag discovery arrays for discovering and validating biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel.
Recommended Stories
- Five stocks we like better than Oncimmune
- What is the FTSE 100 index?
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- Market Cap Calculator: How to Calculate Market Cap
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for Oncimmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncimmune and related companies with MarketBeat.com's FREE daily email newsletter.
